Athira Pharma's total assets for Q2 2025 were $35.55M, a decrease of -18.31% from the previous quarter. ATHA total liabilities were $3.56M for the fiscal quarter, a -42.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.